This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Crispr Therapeutics Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Yvonne Sarah Aratyn: Innovator in Gene Editing
Introduction
Yvonne Sarah Aratyn is a prominent inventor based in Cambridge, MA, known for her contributions to the field of gene editing. With a focus on innovative solutions for genetic conditions, she has made significant strides in biotechnology.
Latest Patents
Yvonne holds a patent for "Compositions and methods for gene editing." This patent provides materials and methods for treating patients with conditions associated with ANGPTL3, whether ex vivo or in vivo. Additionally, it outlines methods for editing and modulating the expression of the ANGPTL3 gene in a cell through genome editing.
Career Highlights
Yvonne is currently associated with Crispr Therapeutics AG, a leading company in the field of gene editing. Her work has been instrumental in advancing therapeutic approaches that leverage CRISPR technology.
Collaborations
Yvonne collaborates with notable colleagues, including Ante Sven Lundberg and Samarth Kulkarni, who contribute to her research and development efforts.
Conclusion
Yvonne Sarah Aratyn's innovative work in gene editing exemplifies the potential of biotechnology to address genetic disorders. Her contributions continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile